Episode Questions and Answers
Who is Chuck Meeker?
Chuck Meeker is the President and Founder of Hyagen Medical and a practicing attorney at Workman Nydegger in Salt Lake City. Chuck Meeker holds a PhD in cancer biology from the Huntsman Cancer Institute at the University of Utah School of Medicine, giving Hyagen Medical a rare combination of scientific and legal expertise inside the regenerative medicine industry.
What is Hyagen Medical?
Hyagen Medical is a Utah turnkey provider that helps healthcare clinics implement stem cell therapy. Hyagen Medical handles product sourcing from FDA-registered processing labs and distributors, plus the legal, regulatory, and compliance documentation required for clinics to operate inside FDA HCT/P guidelines. Visit hyagenmedical.com.
Are stem cells legal in the United States?
Yes. Stem cells are legal in the United States under an FDA compliance pathway for human cells, tissues, and cellular and tissue-based products (HCT/Ps). They are not classified as FDA-approved drugs, but they can be used therapeutically when sourced, processed, and distributed through FDA-registered facilities and marketed in compliance with FDA rules.
Where do ethical stem cells come from?
The stem cells used in compliant US therapy are birth-tissue derived, sourced from the umbilical cord and associated placental tissues after a live, healthy birth. Donor mothers consent voluntarily and are not compensated, similar to organ donation. They are not embryonic stem cells and are not taken from aborted fetuses.
What is the biggest marketing mistake clinics make with stem cells?
Making drug-style claims. Saying stem cells 'treat,' 'cure,' or 'heal' a specific disease or condition is a drug claim, and stem cells are not FDA-approved drugs. The FDA issues more warning letters for non-compliant marketing than for the products themselves. The compliant approach is to describe stem cells as a delivery vehicle for natural growth factors and cytokines, without tying outcomes to disease states.
Should a Utah med spa work with Hyagen Medical?
Med spas are one of the strongest fits for stem cell therapy because growth factors and cytokines support outcomes med spas already pursue, including hair restoration through improved vascular function, reduced cellular debris, and inflammation control. Hyagen Medical provides product sourcing, compliance protocols, and marketing guidance to roll out stem cell therapy as a turnkey service line.
Where is Utah Business Spotlight filmed?
Utah Business Spotlight is filmed in Draper, UT 84020. The show is produced by The INCubator AI Marketing Agency and hosted by Peter Anthony.
Episode Transcript
00:00 Stem cells do not heal the way people think
Chuck Meeker opens with the misunderstanding at the heart of the entire industry: the stem cell itself is not what reduces inflammation, controls cellular growth, clears cellular debris, or grows new blood vessels. The stem cell does not transform into something inside the patient's body. The patient's own body is the powerhouse that accomplishes regenerative medicine. The patient is the hero in their own healing story.
01:06 Why Hyagen Medical exists
Peter Anthony introduces Chuck Meeker as the President and Founder of Hyagen Medical, the company getting the right stem cell products to the right clinicians and building real-time information sharing across the industry. Chuck Meeker explains the trigger event: in mid-2024 the Utah State Legislature passed a law creating a safe harbor for clinical providers to perform stem cell therapy in Utah even without FDA drug approval.
02:00 The biggest misconceptions about stem cells
Chuck Meeker dismantles two myths. First, stem cells are not illegal in the United States, there is a compliant FDA pathway. Second, stem cells sourced inside the United States are not inferior to anything available out of country. The US healthcare system is one of the strongest in the world precisely because it carries the regulations and transparency that give both patients and providers confidence.
03:21 Regulation, transparency, and trust
Chuck Meeker reframes US healthcare regulation as the actual selling point of the model. The same regulatory weight that some operators view as friction is the layer that creates trust between provider and patient, and ultimately the asset that protects the long-term business.
04:23 Where ethical stem cells come from
Chuck Meeker explains that compliant US stem cell therapy uses birth-tissue derived stem cells, the umbilical cord and associated placental tissues collected after a live, healthy birth. These are not embryonic stem cells. Donor mothers consent voluntarily, similar to an organ donor on a driver's license. The US system forbids compensating donor mothers, which removes human trafficking and birth-farm risk from the supply chain.
06:25 Why clinics are turning to stem cell therapy
Chuck Meeker uses the biology to explain the demand. In utero, these stem cells circulate through the umbilical cord and act as carrier vehicles, delivering a portfolio of natural growth factors, cytokines, and chemokines that activate molecular pathways and drive rapid growth in the fetus. Reintroducing those biomolecules into an adult body is what makes the therapy commercially interesting.
09:16 The body is the real powerhouse
Chuck Meeker re-anchors the science: the stem cell is not the actor. The contents inside the stem cell, the growth factors and cytokines, bind to the patient's own cell receptors and switch on regenerative pathways that already exist in the body. The stem cell is a delivery vehicle. The patient's body is the engine.
11:15 Two sides of the stem cell industry
Chuck Meeker separates the field into two markets: tissue engineering, where stem cells are manipulated to become other cell types, like pancreatic islet cells for type 1 diabetes, and stem cell therapy, which is what Hyagen Medical operates inside. Stem cell therapy uses the contents of the stem cell to activate the body's existing systems.
12:39 How Hyagen Medical helps healthcare providers
Chuck Meeker reveals the real positioning of Hyagen Medical: clinicians put their patients first, but nobody is putting the clinician first. Most providers do not have the time to vet sourced products or build legal and regulatory compliance documents on their own. Hyagen Medical is the turnkey infrastructure layer, sourcing, processing, distribution, legal, and regulatory, so a healthcare provider can implement stem cell therapy in a single integration.
14:20 Chuck Meeker's science and legal background
Chuck Meeker shares the credentialing stack behind the company. He is a practicing attorney and partner at Workman Nydegger in Salt Lake City, about 13 years at the firm. His scientific background is molecular biology and biochemistry, with a PhD in cancer biology from the Huntsman Cancer Institute at the University of Utah School of Medicine. The dual lens is what allows Hyagen Medical to translate FDA regulation into operational protocols clinics can actually use.
17:56 The marketing mistake that gets clinics in trouble
Chuck Meeker delivers the line every med spa needs: more FDA warning letters get sent for bad marketing of stem cell products than for bad products. Stem cells are not FDA-approved drugs. They are classified as human cells, tissues, and cellular and tissue-based products (HCT/Ps), and there is a separate regulatory pathway that does not require pre-market approval, provided sourcing, processing, distribution, and marketing all stay compliant.
20:00 What clinics can and cannot say
Chuck Meeker explains the compliant marketing frame. A clinic cannot say 'stem cells treat shoulder pain', that is a drug claim. A clinic can describe the stem cell for what it actually is, a carrier vehicle for natural human growth factors and cytokines, and describe what those biomolecules are known biologically to do, without ever tying outcomes to a disease state. The supplement-style 'these statements have not been evaluated' disclaimers do not provide safe harbor in stem cells.
22:51 How compliance protects the business
Chuck Meeker reframes compliance as protection, not friction. Half of what Hyagen Medical does is provide compliance guidance that keeps a target off a clinic's back. With proper protocols in place, an FDA visit becomes an isolated incident with a warning instead of a business-ending enforcement event. Peter Anthony lays out the operator's stack: attorney first, accountant second, marketing third, most failures happen because owners reverse the order.
24:15 Why med spas need better guidance
Chuck Meeker confirms med spas are one of the strongest fits for stem cell therapy. Hair restoration, for example, is largely a function of vascular health, cellular debris, and inflammation in the scalp, exactly the systems the growth factors and cytokines inside birth-tissue derived stem cells are known to support. Hyagen Medical packages the sourcing, the compliance, and the marketing language so a med spa can roll the service out without exposure.
27:19 Following passion into opportunity
Chuck Meeker closes with the founder advice: follow your passion and keep your eyes open for the opportunities inside it. He pursued cancer biology because of his Huntsman family roots, then realized he wanted more human interaction than a research bench, so he went to law school to work with healthcare-adjacent companies. Peter Anthony reframes it cleanly, do not just follow your passion, follow the opportunities inside your passion.
